Intelligence Platform
Patents
Browse 3,501 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6207412
Identification of a G protein-coupled receptor transcriptionally regulated by protein tyro
expired patentUS 6207403
Kinesin motor modulators derived from the marine sponge Adocia
expired patentUS 6207186
Lamellar gels and methods for making and using
expired patentUS 6207159
Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus
expired patentUS 6204245
Treatment of narcolepsy with immunosuppressants
expired patentUS 6203787
Treating tumors using implants comprising combinations of allogeneic cells
expired patentUS 6203778
Particulate radiopaque contrast agent for diagnostic imaging and microvascular characteriz
expired patentUS 6200811
Cell transformation vector comprising an HIV-2 packaging site nucleic acid and an HIV-1 GA
expired patentUS 6200599
Ortho ester lipids
expired patentUS 6197541
Recombinant thrombin receptors and assays using them
expired patentUS 6197586
Chondrocyte-like cells useful for tissue engineering and methods
expired patentUS 6193965
Oncoprotein kinase
expired patentUS 6194421
Inhibitors of metazoan parasite proteases
expired patentUS 6193963
Method of treating tumor-bearing patients with human plasma hyaluronidase
expired patentUS 6190723
Neutralization of food allergens by thioredoxin
expired patentUS 6191269
Selective induction of cell death by delivery of amino-terminal interleukin-1-.alpha. pro-
expired patentUS 6191103
Methods for enhancing thrombolysis in a mammal
expired patentUS 6190894
Method and compositions for disrupting the epithelial barrier function
expired patentUS 6187814
Treatment of skin conditions with FXR activators
expired patentUS 6183772
Doped colorimetric assay liposomes
expired patentUS 6184215
Treatment of skin conditions with oxysterol activators of LXR.alpha.
expired patentUS 6183961
Methods and compositions for regulating cell cycle progression
expired patentUS 6180142
Reduction of surfactant inactivation in pulmonary surfactant therapy
expired patentUS 6174872
Method for treating allergic lung disease
expired